An AllTrials project

NCT04945772: An ongoing trial by Nanoscope Therapeutics Inc.

This trial is ongoing. It must report results 2 years from now.

Full data

Full entry on ClinicalTrials.gov NCT04945772
Title A Phase 2b Randomized, Double-Masked, Sham-Controlled, Study to Evaluate the Efficacy and Safety of Intravitreal Injection of vMCO-010 Optogenetic Therapy in Adults With Retinitis Pigmentosa [RESTORE]
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date July 13, 2021
Completion date Jan. 1, 2023
Required reporting date Jan. 1, 2024, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Nov. 30, 2021
Days late None